$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Latest Closing Price
$141.38Price-Earnings Ratio
95.53Total Outstanding Shares
46.37 Million SharesDividend
$0.34 Per Share QuarterlySIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
New York Stock ExchangeHeadquarters
550 E Swedesford Rd, Wayne, PA, 19087| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 1,316,281 Shares | 1.84 | 3/14/2025 | 2,422,091 Shares |
| 1,519,045 Shares | 1 | 2/28/2025 | 1,116,134 Shares |
| 516,971 Shares | 2.38 | 2/14/2025 | 1,229,034 Shares |
| 538,457 Shares | 2.13 | 1/31/2025 | 1,148,118 Shares |
| 486,419 Shares | 2.17 | 1/15/2025 | 1,054,028 Shares |
| 491,479 Shares | 1.63 | 12/31/2024 | 801,916 Shares |
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $638.26 Million |
| Net Cash Flow From Investing Activities, Continuing | $-99.36 Million |
| Net Cash Flow From Operating Activities | $635.74 Million |
| Net Cash Flow From Investing Activities, Discontinued | $0 |
| Net Cash Flow | $104.80 Million |
| Net Cash Flow From Investing Activities | $-99.36 Million |
| Metric | Value |
|---|---|
| Income/Loss From Discontinued Operations Net Of Tax | $-487,000 |
| Diluted Average Shares | $47.09 Million |
| Other Operating Expenses | $120.12 Million |
| Income/Loss From Continuing Operations Before Tax | $75.48 Million |
| Gross Profit | $1.70 Billion |
| Depreciation and Amortization | $274.60 Million |
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $-2.26 Million |
| Comprehensive Income/Loss | $67.41 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss Attributable To Parent | $-2.26 Million |
| Comprehensive Income/Loss Attributable To Parent | $67.41 Million |
| Metric | Value |
|---|---|
| Equity | $4.28 Billion |
| Liabilities And Equity | $7.10 Billion |
| Assets | $7.10 Billion |
| Long-term Debt | $1.66 Billion |
| Noncurrent Liabilities | $2.17 Billion |
| Other Current Assets | $870.99 Million |
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 27, 2025 | Mar 17, 2025 | Mar 7, 2025 | $0.34 | Quarterly |
| Oct 31, 2024 | Dec 16, 2024 | Nov 15, 2024 | $0.34 | Quarterly |
| Aug 1, 2024 | Sep 16, 2024 | Aug 15, 2024 | $0.34 | Quarterly |
| May 6, 2024 | Jun 14, 2024 | May 15, 2024 | $0.34 | Quarterly |
| Feb 22, 2024 | Mar 15, 2024 | Mar 1, 2024 | $0.34 | Quarterly |
| Nov 2, 2023 | Dec 15, 2023 | Nov 15, 2023 | $0.34 | Quarterly |